SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-23-093857
Filing Date
2023-12-06
Accepted
2023-12-06 21:43:36
Documents
1
Period of Report
2023-11-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-63735.html 3  
1 PRIMARY DOCUMENT marketforms-63735.xml 3 5516
  Complete submission text file 0001213900-23-093857.txt   8461
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Issuer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 250 EAST 200 SOUTH FLOOR 16 SALT LAKE CITY UT 84111
Business Address 250 EAST 200 SOUTH FLOOR 16 SALT LAKE CITY UT 84111 2122204444
Exploration Capital Fund, LP (Reporting) CIK: 0001799866 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-21088 | Film No.: 231470961

Mailing Address 250 EAST 200 SOUTH, FLOOR 16 SALT LAKE CITY UT 84111
Business Address 250 EAST 200 SOUTH, FLOOR 16 SALT LAKE CITY UT 84111 (212) 220-4444
Exploration Capital General Partner, LLC (Reporting) CIK: 0002003481 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-21088 | Film No.: 231470959

Mailing Address 250 EAST 200 SOUTH, FLOOR 16 SALT LAKE CITY UT 84111
Business Address 250 EAST 200 SOUTH, FLOOR 16 SALT LAKE CITY UT 84111 (212) 220-4444
Exploration Capital, LLC (Reporting) CIK: 0002003514 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-21088 | Film No.: 231470960